Budget Amount *help |
¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2014: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
|
Outline of Final Research Achievements |
To develop novel interventional therapy for liver metastases from pancreatic cancer. First, in ex vivo study, feasibility of bead-TAE using arterial port system was examined. Beads under 500um in size could pass through the port. Next, for hypovascular liver metastases, bland-TAE using beads was conducted, and high anti-tumor effect was shown. In a study of irinotecan eluting beads, using VX2 tumor rabbits, 40um beads TACE was conducted and histologically beads were distributed inside of the tumors with high necrotic ratio and also pharmacological advantage was shown.
|